ClinicalTrials.gg

Merz Pharma clinical trials

Part of Merz Holding GmbH & Co. KG.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 172 studies whose lead sponsor is Merz Pharma or one of 6 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 6 registry names, not the registry’s. See them and correct one ↓

Compare Merz Pharma with Pfizer and H. Lundbeck →

Pipeline: 1 program

Each counted once: 1 with a study Merz Pharma leads registered in the last two years.

  • Phase 4 (approved, new studies)

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Merz Pharma’s own registered studies; Merz Pharma’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Merz Pharma’s studies test, most studies first; none is open now — 8 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

5 of Merz Pharma’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. 2M
  6. A
  7. M
  8. J
  9. J
  10. 2A
  11. S
  12. O
  13. N

Add all 5 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 172 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now32%
  • Under way, not recruiting63%
  • Completed14584%
  • Stopped early1810%Terminated 14 · Withdrawn 4

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 2611
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 326

By the year each study started; 8 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Merz Pharma.

  • Merz Pharmaceuticals GmbH
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    61 studies →
  • Merz North America, Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    53 studies →
  • Ulthera, Inc
    Acquired — became part of Merz Pharma, Jul 29, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    46 studies →
  • Merz Therapeutics GmbH
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Merz Aesthetics GmbH
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • ON Light Sciences
    Acquired — became part of Merz Pharma, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 50 of 172. Browse all 172 →